দেশ: অস্ট্রেলিয়া
ভাষা: ইংরেজি
সূত্র: APVMA (Australian Pesticides and Veterinary Medicines Authority)
OESTRADIOL BENZOATE
SYNTEX S.A.
oestradiol benzoate(1mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
OESTRADIOL BENZOATE STEROID-ESTROGEN Active 1.0 mg/ml
100 mL; 50 mL
VM - Veterinary Medicine
ENDOCRINE SYSTEM
Poison schedule: 4; Withholding period: WHP: Zero (0) days ESI: Zero (0) days; Host/pest details: CATTLE: [ANOESTRUS, INDUCTION OF OVULATION, SYNCHRONISATION OF OESTRUS & OVULATION]; Poison schedule: 4; Withholding period: ; Host/pest details: CATTLE: [ANOESTRUS, INDUCTION OF OVULATION, SYNCHRONISATION OF OESTRUS & OVULATION]; To improve the precision of the onset of oestrus and maximise fertility in oestrus synchronization programmes using an intravaginal insert containing progesterone in cycling cattle. To induce oestrus and ovulation after progesterone priming with an intravthis product is contraindicated for administration in high doses to pregnant cattle as this has been shown to cause abortion.
Registered
2023-07-01
BOEHRINGER INGELHEIM PTY LIMITED, VETMEDICA DIVISION GONADIOL 82023/104815 Company Name: Product Name: APVMA Approval No: Label Name: GONADIOL Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 1 mg/mL oestradiol benzoate Claims: To improve the precision of the onset of oestrus and maximise fertility in oestrus synchronization programmes using an intravaginal insert containing progesterone in cycling cattle. To induce oestrus and ovulation after progesterone priming with an intravaginal insert containing progesterone in the treatment of anoestrus in cattle. Net Contents: 50 mL 100 mL Directions for Use: Restraints: Contraindications: This product is contraindicated for administration in high doses to pregnant cattle as this has been shown to cause abortion. Precautions: Side Effects: Dosage and Administration: Discard any unused product within 24 hours of first broaching the container. Inject by intramuscular injection. RLP APPROVED For use in oestrus synchronization programmes and treatment of anoestrus in cattle: Inject 2 mL at the time of administration of the intravaginal insert containing progesterone. Inject a further 1 mL between 24 and 48 hours after the removal of the intravaginal insert containing progesterone. General Directions: MODE OF ACTION: The intramuscular injection of oestradiol benzoate at the initiation of progesterone treatment in cycling cattle (e.g. at the same time as the administration of an intravaginal insert containing progesterone) results in follicular turnover and the emergence of a new follicular wave about four days after treatment. The synchronous emergence of this new follicular wave both enhances the precision of the onset of oestrus and ensures a high fertility oocyte at ovulation after the cessation of progesterone treatment. The intramuscular injection of oestradiol benzoate during the pro-oestrus period, induced by progesterone priming (e.g. following removal of the intravaginal insert containing prog সম্পূর্ণ নথি পড়ুন